---
title: "Why GOP adviser Brian Blase still supports Medicaid cuts and what’s unclear next"
id: "news-news-stat-bd1796a1173010f8a8be18e9"
canonical_url: "https://medichelpline.com/news/news-news-stat-bd1796a1173010f8a8be18e9"
content_type: "medical_news_article"
category: "Health"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/09/22/brian-blase-paragon-health-institute-gop-aca-medicaid-reforms/?utm_campaign=rss"
published_at: "2026-09-22T08:30:00.000Z"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Why GOP adviser Brian Blase still supports Medicaid cuts and what’s unclear next
## Metadata & Source Attribution
- **Canonical URL:** https://medichelpline.com/news/news-news-stat-bd1796a1173010f8a8be18e9
- **Category:** [Health](https://medichelpline.com/news/health.md)
- **Reporting Source:** STAT News
- **Original Source URL:** [Read Original Article](https://www.statnews.com/2026/09/22/brian-blase-paragon-health-institute-gop-aca-medicaid-reforms/?utm_campaign=rss)
- **Published At:** 2026-09-22T08:30:00.000Z
## Executive Summary & Key Highlights
- Brian Blase, president of the **Paragon Health Institute**, has been a key adviser to House Republicans and backed the recent overhaul of federal health funding. - The law known as the **One Big Beautiful Bill Act** included changes to **Medicaid** that are expected to reduce the program’s spending by about **$1 trillion** over the coming decade, according to the reporting. - Preliminary estimates from the nonpartisan Congressional Budget Office say roughly **7 million people** could lose Medicaid coverage because of the policy changes. - Health providers, including rural hospitals, are reported to be scrambling and rethinking care delivery in response to the cuts. - STAT’s story reports that Blase argues critics overlook important reasons to support the cuts, but the article’s detailed analysis and full explanation were behind STAT+ paywall and not included in the public excerpt. - The article notes Blase’s influence in Congress and that lawmakers used the Medicaid cuts to offset tax cuts passed last year, but it does not provide comprehensive details about Blase’s next policy target or the substance of his arguments in the excerpt provided.
## In-Depth Reporting & Editorial Analysis
## Overview: who Brian Blase is and what changed Brian Blase, president of the **Paragon Health Institute**, has emerged as a prominent adviser to House Republicans on health policy. According to STAT, Republicans in Congress enacted sweeping changes last year to federal health funding, and Blase supported policy shifts that significantly alter the future of **Medicaid** financing. The changes were enacted as part of legislation referred to in reporting as the **One Big Beautiful Bill Act**. Those changes are expected to reduce Medicaid program outlays by roughly **$1 trillion** over the next decade, a figure cited in the article. The nonpartisan Congressional Budget Office has produced a preliminary estimate that about **7 million people** could lose Medicaid coverage as a result of the revisions. ## Why Blase still supports the cuts (as reported) STAT reports that Blase continues to back the Medicaid funding changes despite public and provider backlash. The article says Blase contends critics are overlooking what he considers key arguments in favor of the reforms. The publicly available portion of the article does not include the full substance of his reasoning; the in-depth explanation and specific arguments were presented in the STAT+ subscriber-only portion and were not reproduced in the excerpt. What is clear from the reporting is Blase’s role: he has been a trusted adviser whose ideas helped shape the policy direction that lawmakers ultimately adopted. The piece links his influence to the adoption of the Medicaid provisions used to partially offset fiscal changes elsewhere in federal policy. ## Immediate and projected impacts on coverage and providers The reporting connects the legislative changes to concrete, early effects. Providers — particularly some rural hospitals — are reported to be scrambling to adapt to the policy shift. STAT referenced broader reporting about how hospitals are rethinking care delivery in response to reduced Medicaid funding. On coverage, the CBO’s preliminary estimate of roughly **7 million** people losing Medicaid underscores the scale of potential enrollment fallout. The article frames that figure alongside the long-term fiscal estimate of about **$1 trillion** less in Medicaid outlays over the coming decade. ## Political context and how the cuts were used Blase’s policy work came amid wider Republican efforts to reshape federal health spending. STAT notes that Congress used the Medicaid funding changes to offset the cost of tax cuts approved in the prior year. That legislative tradeoff is central to how the Medicaid changes were both adopted and criticized. The article also emphasizes Blase’s standing with Republican lawmakers. It describes him as a trusted adviser whose policy positions carried weight as the party crafted and implemented changes to the health care funding framework. ## What the article says — and what it does not report Readers should be aware that the STAT story was published as a subscriber-only piece (STAT+). The publicly available excerpt summarizes Blase’s continued support and the immediate consequences of the policy changes but directs readers to the paid section for the full account. Consequently, the excerpt does not provide: - The complete list or text of the arguments Blase advances in support of the Medicaid cuts. - Detailed, sourced descriptions of the next policy target Blase may pursue, despite the story’s headline suggesting there may be a subsequent focus. - Full interviews, internal documents, or extended examples that might appear in the subscriber version. Because the detailed analysis and Blase’s full explanations were behind the STAT+ paywall, this rewrite limits itself to the facts and figures presented in the public portion of the article. ## What’s next: uncertainty about future policy moves The story’s headline indicates there may be a “next” policy target for Blase and aligned lawmakers, but the excerpted article does not specify what that target is. STAT reported Blase’s influence and his continued public backing of the Medicaid changes, while the deeper reporting that could identify subsequent initiatives or precise policy plans was not available in the public text. Observers of health policy should expect continued political debate over the Medicaid changes and potential follow-on proposals from influential advisers and lawmakers. The reporting that is publicly accessible documents immediate effects on coverage projections and provider operations, and it establishes Blase as a central figure in that policy shift. ## Bottom line STAT’s reporting identifies Brian Blase and the **Paragon Health Institute** as influential in shaping recent Republican-led changes to **Medicaid** financing. Those changes — enacted as part of the One Big Beautiful Bill Act — are projected to lower Medicaid outlays by about **$1 trillion** over the coming decade and could lead to approximately **7 million** fewer people on Medicaid, per preliminary CBO figures cited in the piece. Health providers are reported to be adjusting their operations in response. The article indicates Blase maintains public support for the cuts and that he believes critics are missing important considerations, but the detailed rationale and any specific next policy target were contained in the STAT+ subscriber-only portion and were not included in the public excerpt filed with the story. For readers seeking the full reporting and Blase’s full reasoning, STAT’s subscriber access was required at the time of publication. Reporting details: Daniel Payne, STAT, Sept. 22, 2026. The publicly available excerpt on which this rewrite is based did not include the full subscriber material.
## Navigation
- [← Back to Health News](https://medichelpline.com/news/health.md)
- [← All Medical News Categories](https://medichelpline.com/news.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.